INMB
INmune Bio Inc
2.20$
-5.7%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | -100.0% | +1,558.1% | +106.6% | -58.6% | -91.0% | +257.1% | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -100.0% | +1,558.1% | +106.6% | -58.6% | -91.0% | +257.1% | |
| – | +0.0% | +328.9% | +153.9% | +196.9% | +80.3% | +247.2% | -16.9% | +18.8% | +63.6% | -37.7% | |
| – | -35.5% | +333.4% | +1,975.5% | -46.9% | +5.1% | +39.1% | +5.3% | +3.9% | -1.5% | +8.2% | |
| – | +365.5% | +331.4% | +1,167.5% | -37.7% | +57.8% | +139.7% | -10.3% | +13.6% | +42.7% | -27.5% | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | +13.6% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -108.8% | – | +13.6% | -2,306.3% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | -134.1% | – | -8,393.9% | – | – | – | – | – | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.